Abstract | OBJECTIVE: to evaluate the feasibility, tolerance/toxicity and therapeutic efficacy of 5-fluorouracil (5-FU) by topical application and systemic use, in facial carcinoma associated with XP. METHODS AND PATIENTS: This is a prospective study of 10 patients with a median age of 22.9 years and a sex ratio of 4. Tumour lesions were facial mainly in the jugal and temporal region (36%). Chemotherapy indication was discussed in multidisciplinary committee, the topical 5-fluorouracil was applied locally twice a day, whereas the systemic treatment consisted of FUFOL protocol (every 4 weeks a combinaison of a short perfusion of 340 mg/m2 5-FU and preceded by an infusion of 20mg/m2 of folic acid, day 1 to 5); or C-FU protocol, combining continuous infusion of 5-FU (1 g/m2) 5 days associated with cisplatin (100 mg/m2, day 1) every 3 weeks. RESULTS: The median topical treatment duration was of 12 months in 10 patients. We noted a full tumoral regression in 10% of cases. Concerning systemic treatment, the median number of FUFOL cycles was 4 (2 to 6) and we observed a complete response in 6 patients (60%), partial in 2 cases (20%). Treatment was well tolerated in most cases except for the cutaneous irritation on 5-FU application zone and a 4 grade cisplatin otoxicity. CONCLUSION: Systemic or topical chemotherapy represents an interesting palliative option for facial carcinoma associated with XP, avoiding reiterated surgery and its cosmetic consequences.
|
Authors | Abir Khader, Saïd Gritli, Ilhem Boussen, Z Oueslati, Mohamed Ferjaoui, R Nouira, A Ladgham, Hamouda Boussen |
Journal | La Tunisie medicale
(Tunis Med)
Vol. 83
Issue 11
Pg. 672-4
(Nov 2005)
ISSN: 0041-4131 [Print] Tunisia |
Vernacular Title | Chimiotherapie locale et systemique par 5-fluorouracile dans les carcinomes de la face secondaires au xeroderma pigmentosum. |
PMID | 16422364
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Antimetabolites, Antineoplastic
- Antineoplastic Agents
- Cisplatin
- Fluorouracil
|
Topics |
- Administration, Cutaneous
- Adolescent
- Adult
- Antimetabolites, Antineoplastic
(administration & dosage, therapeutic use)
- Antineoplastic Agents
(administration & dosage)
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Carcinoma
(drug therapy)
- Child
- Child, Preschool
- Cisplatin
(administration & dosage)
- Facial Neoplasms
(drug therapy, pathology)
- Feasibility Studies
- Female
- Fluorouracil
(administration & dosage, therapeutic use)
- Humans
- Infusions, Intravenous
- Male
- Middle Aged
- Palliative Care
- Prospective Studies
- Skin Neoplasms
(drug therapy, pathology)
- Xeroderma Pigmentosum
(pathology)
|